Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Jason J. Luke, Manish R. Patel, Erika Paige Hamilton, Bartosz Chmielowski, Susanna Varkey Ulahannan, Hedy L. Kindler, Shakeela Wazeen Bahadur, Philip R. Clingan, Girish Mallesara, Andrew James Weickhardt, Scott Currence, Linzhi Xu, Sanjeev Kaul, Francine Chen, Paul A. Moore, Ezio Bonvini, Brad Sumrow, George Blumenschein | ||||||||||||
Title | A phase I, first-in-human, open-label, dose-escalation study of MGD013, a bispecific DART molecule binding PD‑1 and LAG‑3, in patients with unresectable or metastatic neoplasms. | ||||||||||||
|
|||||||||||||
URL | https://meetinglibrary.asco.org/record/185039/abstract | ||||||||||||
Abstract Text | J Clin Oncol 38: 2020 (suppl; abstr 3004), DOI: 10.1200/JCO.2020.38.15_suppl.3004 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|